GLTO — Galecto, Inc. | SharesGrow.com

Galecto, Inc. (GLTO) 是一家生物科技公司，屬於醫療保健產業, 目前交易價格為 $26.62. 其SharesGrow評分為 51/100, 表明一般的投資特徵， 7項中通過3項.

分析師共識目標價為 GLTO = $44 (+64% 上漲空間).

估值: GLTO 本益比(P/E)為 -0.2 (S&P 500平均約25).

淨利潤為 $210M (虧損), 成長率為 -265.5%/yr. 淨利潤率為 0% (較薄). 毛利率為 0% (+0 pp 趨勢).

資產負債表: 總債務為 $1M 對比 $240M 股東權益 (D/E比率 0.01, 保守). 流動比率為 12.98 (流動性強). 資產負債率為 0.5%. 總資產: $261M.

分析師展望: 3 / 5 位分析師評級 GLTO 為買入 (60%) — 適度共識.

SharesGrow 7項標準細分: Value 100/100 (Pass), Growth 15/100 (Fail), Past 0/100 (Fail), Health 100/100 (Pass), Moat 28/100 (Fail), Future 73/100 (Pass), Income ?/100 (Fail).

$43.67

▲ 64.05% 上漲空間

Average Price Target

基於 5 位華爾街分析師對 Galecto, Inc. 提供的12個月價格目標，平均目標價為 $43.67，最高預測為 $46.00，最低預測為 $40.00。

Highest Price Target

$46.00

Average Price Target

$43.67

Lowest Price Target

$40.00

GLTO SharesGrow 評分概覽

63/100

SharesGrow Score

Above average fundamentals

View full scorecard →

價值 100/100

估值 — P/E, PEG, Forward PEG

成長 15/100

財務數據 — 平均成長

過去 0/100

強勁 — 趨勢

健康 100/100

資產負債表 — D/E比率, 流動比率為

護城河 28/100

毛利率為 + market cap

未來 73/100

分析師展望 — 為買入

收入 0/100

淨利潤率為

Scores derived from financial statements, analyst ratings, and balance sheet data.

評分明細 — GLTO

✓

價值 Pass

100/100

GLTO 本益比(P/E)為 -0.2 (S&P 500平均約25). 分析師共識目標價為 $44, 意味著 +65.3% 相對於當前價格 $27. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上漲空間 (25%) + trailing PEG (20%). ≥ 60 = Pass.

GLTO: +0%/yr 營收為, -265.5%/yr 淨利潤為平均成長. 較弱. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

No analyst coverage available for this stock.

✓

健康 Pass

100/100

資產負債表 GLTO: D/E比率 0.01 (保守), 流動比率為 12.98 (流動性強). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

GLTO: 毛利率為 0% (+0 pp 趨勢), N/A market cap. Moat (0-100): margin (35%) + 趨勢 (15%) + market cap (30%) + 營收為 (20%). Score 28/100. ≥ 70 = Pass.

分析師展望: 3 / 5 位分析師評級 GLTO 為買入 (60%). 分析師共識目標價為 $44 (+65.3% 上漲空間). Score: 60% buy consensus + 40% 上漲空間. ≥ 60 = Pass.

No analyst coverage available for this stock.

Stock Chart & Stats

市場數據

52週區間2.01-38.325

成交量1.09K

30日平均成交量393.98K

市值$42.52M

Beta（1年）1.57

Share Statistics

EPS（TTM）-3.98

流通股數$2.33M

IPO Date2020-10-29

Employees5

CEOLori C. Firmani

Financial Highlights & Ratios

Gross Profit$-174.31M

EBITDA$-36.53M

Net Income$-209.84M

Operating Income$-36.56M

Total Cash$257.62M

Total Debt$1.41M

Net Debt$-256.22M

Total Assets$260.53M

Price / Earnings (P/E)-6.7

Analyst Forecast

1Y Price Target$45.00

Target High$46.00

Target Low$40.00

上漲空間+69.0%

評級共識Buy

覆蓋分析師數5

買入 60% 持有 40% 賣出 0%

Price Target Summary

公司資訊

國家US

交易所NASDAQ Global Select

貨幣USD

ISINUS36322Q2066

股價走勢

GLTO

Galecto, Inc. ↗ · NASDAQ Global Select

Healthcare • Biotechnology

2.01 52WK RANGE 38.33

其他人也在看

RVMD

Revolution Medicines, Inc.

$152.54

+3.76%

CNTA

Centessa Pharmaceuticals plc

$39.61

+0.05%

TERN

Terns Pharmaceuticals, Inc.

$52.71

+0.06%

EWTX

Edgewise Therapeutics, Inc.

$33.70

+1.63%

DAWN

Day One Biopharmaceuticals, Inc.

$21.47

+0.05%

AMLX

Amylyx Pharmaceuticals, Inc.

$17.12

+1.18%

MLTX

MoonLake Immunotherapeutics

$18.02

-4.05%

GLUE

Monte Rosa Therapeutics, Inc.

$18.23

+4.17%

Galecto, Inc. GLTO NASDAQ

GLTO SharesGrow 評分概覽

評分明細 — GLTO

Stock Chart & Stats

股價走勢

其他人也在看

獲取低估股票提醒